Liling Qin
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Immunotherapy and Immune Responses 3
- interferon and immune responses 3
- Immune Cell Function and Interaction 2
- Oncology 5
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Weijia Liao (12 shared papers)Shengguang Yuan (4 shared papers)Songqing He (2 shared papers)Jianan Wu (1 shared paper)Yan Liao (5 shared papers)Peng‐Peng Zhu (4 shared papers)Ran Fei (6 shared papers)Qun Zhu (1 shared paper)
- Journals
- Scientific Reports (2 papers)Diagnostic Pathology (1 paper)Clinical Cancer Research (1 paper)Journal of Nuclear Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Liling Qin
19 papers receiving 372 citations
Peers
Comparison fields: 5 of 56
- Hepatology 51
- Immunology 107
- Oncology 125
- Cancer Research 60
- Molecular Biology 101
Countries citing papers authored by Liling Qin
This map shows the geographic impact of Liling Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liling Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liling Qin more than expected).
Fields of papers citing papers by Liling Qin
This network shows the impact of papers produced by Liling Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liling Qin. The network helps show where Liling Qin may publish in the future.
Co-authors
The 25 scholars most cited alongside Liling Qin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2013 | 74 | |
| 3 | 2004 | 57 | |
| 4 | 2013 | 34 | |
| 5 | 2015 | 24 | |
| 6 | 2023 | 23 | |
| 7 | 2007 | 20 | |
| 8 | 2017 | 14 | |
| 9 | 2017 | 14 | |
| 10 | 2017 | 10 | |
| 11 | 2021 | 8 | |
| 12 | [Correlation between interleukin-28B genetic polymorphisms and primary hepatocellular carcinoma]. | 2012 | 5 |
| 13 | [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients]. | 2007 | 4 |
| 14 | 2025 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2017 | 2 | |
| 18 | [The genetic polymorphism of melanoma-associated antigen 1 in Chinese normal donors and hepatoma patients]. | 2004 | 2 |
| 19 | 2017 | 2 | |
| 20 | 2022 | 0 |
About Liling Qin
Liling Qin is a scholar working on Immunology, Oncology, Epidemiology, Hepatology and Molecular Biology, having authored 21 papers that have together received 377 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (3 papers), Immunotherapy and Immune Responses (3 papers), interferon and immune responses (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Glycosylation and Glycoproteins Research (2 papers), Lipid metabolism and disorders (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hepatology (51 citations), Immunology (107 citations), Oncology (125 citations), Cancer Research (60 citations) and Molecular Biology (101 citations). Liling Qin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Weijia Liao, Shengguang Yuan, Songqing He, Jianan Wu, Yan Liao, Peng‐Peng Zhu, Ran Fei, Qun Zhu, Wenmin Yao and Biao Lei. Their work appears in journals such as Scientific Reports, Diagnostic Pathology, Clinical Cancer Research, Journal of Nuclear Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.